Hannah Clarke

"One of the things that made a difference, at least in my practice, was one of the newer pulse modulated holmium lasers," says Smita De, MD, PhD.

"Our most significant finding may be that patients experience financial toxicity despite their ability to remain compliant with treatment," says Daniel D. Joyce, MD.

"The fact that we are able to swab and look at these proteins means that we might be able to identify women at risk early on,” says Maria Florian-Rodriguez, MD.

A group of patients were shown to have an average of 6.3 cystitis episodes per year before administration of Lactobacillus, compared with 2.4 episodes after administration.

The study will assess the ability of Cu-64 SAR-bisPSMA to detect prostate cancer within the pelvic lymph nodes.

"Another thing is to customize your EHR with favorite orders and grouped orders, and these things can be standardized across a practice," says Sarah Hecht, MD.

"The high reproducibility of reader results across all regions is clinically valuable, with the potential to influence patient management prior to surgery for patients with newly diagnosed disease," says Phillip H. Kuo, MD, PhD.

"Personalized dosing allowed one-third of the men in this study to have treatment breaks while still achieving the same progression-free and overall survival outcomes they would have if they received continuous treatment," says Andrew Nguyen, MBBS, FRACP, AANMS.

The new space includes a clinical laboratory for IsoPSA testing, labs for research and development, offices, and manufacturing spaces for production and distribution of in vitro diagnostic kits.

Investigators assessed integration of mGPS for risk stratification based on data from the phase 3 IMmotion151 study and the phase 2 IMmotion150 study.

"About 29% of our high-risk patients tested AI biomarker negative, and they could thus be spared the long-term [adverse] effects of ADT for 2 to 3 years," says Andrew J. Armstrong, MD, MSc.

"The integration of APPs in urologic practice could play a critical role in addressing the current urologist shortages, [issues with] access, and delivery of urological care across United States," says Omer Raheem, MD, MSc, MCh Urol, MCRSI.

“Our results support the notion that mpMRI is an inadequate screening tool for locally advanced [prostate cancer] and should not be used as the sole means of presurgical [prostate cancer] staging," wrote the authors.

The multiplex polymerase chain reaction/pooled antibiotic susceptibility test was associated with a 44.4% lower mean total UTI-related cost compared to standard urine culture.

Flotufolastat F 18 was granted FDA approval on May 25, 2023 based on data from the phase 3 SPOTLIGHT and LIGHTHOUSE trials.

"I tried to highlight how race has been used in medical research, specifically analyzing how this may [be] used toward Black people as a way to uphold systems of oppression," says Randy Vince, Jr., MD, MS.

Among patients who did not have a response during the first cycle, 60.8% achieved a response after the fourth.

5-year OS was similar between the cohorts, with a rate of 57% among patients who underwent RARC, compared with 55% among those who underwent ORC.

“Our results suggest that bladder-sparing treatments may be a safe approach in selected patients. Survival outcomes were not inferior compared to early radical cystectomy," says Wei Shen Tan, MD.

"The most alarming finding is that there were 0 instances of DREs in the NAMCS dataset over the entire 5-year period, and there were no PSAs conducted in American Indian/Alaska Native men after 2014,” says Christopher M. Gillette, PhD.

"This [guideline]... is probably the most broad in scope and incorporates a lot of the things that were missing or not yet mature enough to be included in the previous guidelines," says Badrinath Konety, MD, MBA.

"We successfully demonstrated that the overexpression of TRAF4 prompts the conversion of androgen-sensitive prostate cancer cells into castration-resistant cells,” says Ping Yi, PhD.

A total of 74.3% of respondents indicated that more training dedicated to care for patients in the LGBT community was needed.

“Combined MRI-targeted and systematic biopsies were nearly twice as likely to result in downgraded pathology at prostatectomy compared [with] systematic biopsies," says Ilon C. Weinstein.

"ChatGPT not only has a low rate of correct answers regarding clinical questions in urologic practice, but also makes certain types of errors that pose a risk of spreading medical misinformation," says Christopher M. Deibert, MD, MPH.

“We are excited to report that a simple, low-cost intervention can positively [affect] young men’s willingness to engage with their health," says Wade Gutierrez.

"One of the notable things was the complications are frequent—which is something that was previously known about these surgeries—but they're minor," says Kayla Blickensderfer.

Projections were made under 3 different circumstances: the rate of women entering urology continues to follow logistic growth, there is no further growth of women into urology, and retirement rates among women mirror that of men in urology.

"Among our accomplishments were the first robotic ureteral reconstructions and completing our first 100 robotic cases within the first half-year," says Michael W. Witthaus, MD.

“This research shows the importance of diversity in clinical trials," said lead author Daniel J. George, MD.